Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism (Q38175317)

30 August 2017

Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism (English)

1 reference

30 August 2017

1 reference

Armando L Negri

1

1 reference

PubMed ID

24384877

30 August 2017

Vincent M Brandenburg

series ordinal

2

1 reference

30 August 2017

3 January 2014

1 reference

International Urology and Nephrology

30 August 2017

1 reference

30 August 2017

46

1 reference

30 August 2017

1145-1151

1 reference

30 August 2017

6

1 reference

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

30 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: Responsiveness is related to parathyroid gland size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Calcification and cardiovascular problems in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Use of 3-hour daily hemodialysis and paricalcitol in patients with severe secondary hyperparathyroidism: A case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Influence of PTH assay methodology on differential diagnosis of renal bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Genetics and biology of vitamin D receptor polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Vitamin D receptor polymorphisms and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

Response of parathyroid glands to calcitriol in culture: Is this response mediated by the genetic polymorphisms in vitamin D receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0637-2

The BsmI vitamin D-receptor polymorphism and secondary hyperparathyroidism

21 January 2018

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients

1 reference

12 December 2020

Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients

1 reference

12 December 2020

Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism

1 reference

12 December 2020

BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients.

1 reference

12 December 2020

Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol.

1 reference

12 December 2020

1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis

1 reference

12 December 2020

Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial

1 reference

12 December 2020

Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.

1 reference

12 December 2020

Evaluation of different bone markers in hemodialyzed patients

1 reference

12 December 2020

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients

1 reference

12 December 2020

Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients

1 reference

12 December 2020

Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure

1 reference

12 December 2020

Influence of Bsml vitamin D receptor gene polymorphism on the response to a single bolus of calcitrol in hemodialysis patients

1 reference

12 December 2020

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

1 reference

12 December 2020

Is parathyroid hormone measurement useful for the diagnosis of renal bone disease?

1 reference

12 December 2020

Persistent secondary hyperparathyroidism after renal transplantation

1 reference

12 December 2020

BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients

1 reference

12 December 2020

10.1007/S11255-013-0637-2

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24384877